DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / ImmunOs Therapeutics AG
ImmunOs Therapeutics AG
Stage unknownUS
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- $11.0Msum of rounds with a disclosed amount only
- Named investors
- 4
Financing history
1 rounds
- Sep 17, 2024Funding round · $11.0M (disclosed)Gimv (participant)Pfizer Ventures (participant) via Michael BaranMission Biocapital (participant) via Steve TregayBioMed Partners (participant)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base”
Investors on record
4 edges
- BioMed Partners round, participant Fact globenewswire.com
- Gimv round, participant Fact globenewswire.com
- Mission Biocapital round, participant, Steve Tregay (confirmed) Fact globenewswire.com
- Pfizer Ventures round, participant, Michael Baran (confirmed) Fact globenewswire.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Sep 17, 2024ImmunOs Therapeutics AG announced Funding round of $11,000,000Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company
- Round announced: Funding round $11,000,000 Sep 17, 2024 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)